Current Health · 1 week ago
Accounting Manager / Financial Controller
Current Health is a purpose-driven business focused on a high-impact corner of healthcare. This role will partner with customers to design, build, and scale outpatient and community models for advanced therapies.
Health CareHome Health CareMedical Device
Responsibilities
Build a new offering within Current Health that provides advisory and consulting services to community-and health system-based provider organizations seeking to establish and operate outpatient/community cell & gene therapy programs, as well as other acute & complex home-based care programs
Partner with community-based and health-system based providers, clinicians and operational leaders to enable them to stand-up and operate community and outpatient cell & gene therapy programs, as well as other acute & complex home-based care programs
Support our community and health system partners to negotiate with and contract with commercial and government payers for appropriate reimbursement of cell & gene therapies, as well as other acute & complex home-based care programs
Create & develop local/regional/national partnerships as required to support community-based complex programs e.g. home care, phlebotomy services, drug delivery etc
Some travel required
Qualification
Required
Deep understanding of the operational, clinical financial workflows around both inpatient and outpatient cell & gene therapy programs
Prior track record of success planning and establishment of new outpatient and ambulatory delivery models
Prior experience with payer negotiations and contracting for cell & gene therapies
Prior experience in delivering advisory & consulting engagements would be a plus, but is not a requirement
Preferred
Licensed provider
Clinician executive
MBA
Company
Current Health
We help healthcare reduce risk & cost by monitoring, managing and engaging patients at home.
Funding
Current Stage
Growth StageTotal Funding
$92.72MKey Investors
Northpond VenturesDexcomMMC Ventures
2021-10-12Acquired
2021-04-22Series B· $43M
2020-06-17Series A· $4.17M
Recent News
2025-12-31
2025-10-06
Company data provided by crunchbase